| Literature DB >> 17570110 |
Thijs J W van de Laar1, Akke K van der Bij, Maria Prins, Sylvia M Bruisten, Kees Brinkman, Thomas A Ruys, Jan T M van der Meer, Henry J C de Vries, Jan-Willem Mulder, Michiel van Agtmael, Suzanne Jurriaans, Katja C Wolthers, Roel A Coutinho.
Abstract
We retrospectively screened 1836 men who have sex with men (MSM) participating in the Amsterdam Cohort Studies (1984-2003) for hepatitis C virus (HCV) antibodies. HCV incidence was 0.18/100 person-years (PY) in human immunodeficiency virus (HIV)-positive MSM (8/4408 PY [95% confidence interval {CI}, 0.08-0.36]) but was 0/100 PY in MSM without HIV (0/7807 PY [95% CI, 0.00-0.05]). After 2000, HCV incidence among HIV-positive men increased 10-fold to 0.87/100 PY (5/572 PY [95% CI, 0.28-2.03]). Additional hospital cases (n=34) showed that MSM in Amsterdam who acquired HCV infection after 2000 reported high rates of ulcerative sexually transmitted infections (59%) and rough sexual techniques (56%), denied injection drug use, and were infected mainly with the difficult-to-treat HCV genotypes 1 (56%) and 4 (36%). Phylogenetic analysis showed 3 monophyletic clusters of MSM-specific HCV strains. The emergence of an MSM-specific transmission network suggests that HIV-positive MSM with high-risk sexual behaviors are at risk for sexually acquired HCV. Targeted prevention and routine HCV screening among HIV-positive MSM is needed to deter the spread of HCV.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17570110 DOI: 10.1086/518796
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226